Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > SVA Fair value is $2.08 according to MS

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Apr 16, 2021 1:10pm

129 Views

Post# 33011766

RE:RE:RE:RE:RE:RE:RE:SVA Fair value is $2.08 according to MS

It has outgrown him as a one man show and CDO would be welcomed. It's time to build a team and I suspect he's already well on the way. Feedback is helpful but it's only been a few months since they have had the cash to grow into a half a billion dollar business.

<< Previous

Bullboard Posts

Next >>

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures